XML 24 R9.htm IDEA: XBRL DOCUMENT v3.24.3
Inventory
9 Months Ended
Sep. 30, 2024
Inventory  
Inventory

3. Inventory

Inventories are stated at the lower of average cost or net realizable value and consist of the following:

    

September 30, 

    

December 31, 

2024

2023

Raw materials

$

2,607

$

Work in process

 

4,835

 

Inventory

$

7,442

$

Recognized as:

Inventory

$

38

$

Other assets

7,404

Prelaunch Inventory

During the nine months ended September 30, 2024, we capitalized costs of $7.4 million associated with the production of YUTREPIA as a result of our determination that regulatory approval and subsequent commercialization is probable, and we also expect future economic benefit from the sales of YUTREPIA to be realized.

Amounts recognized as Other Assets are comprised entirely of raw materials and work in process inventories not expected to be sold within one year of the balance sheet date.